Peptide therapy TikTok claims: what the science actually supports

What did @dearmedia actually say?

The creator's core argument is reasonable and refreshingly cautious: peptides are "tools in the toolkit," not magic compounds. They correctly identified insulin as a peptide synthesized in the 1920s, called out glutathione as a naturally produced peptide, and named BPC-157, TB-500, and GHK-Cu as examples of newer therapeutic peptides. Crucially, they said these are "not wonder drugs or compounds that just magically fix things overnight." That framing alone puts this video ahead of most peptide content on TikTok.

They also flagged something genuinely worth worrying about: people injecting peptides without monitoring their bodies or even knowing what they're using. That's a real and underreported problem in the self-optimization space.

Does the science back this up?

Mostly, yes, with some important gaps. Insulin is indeed a peptide hormone, and its synthesis by Banting and Best in 1921 (published 1922 in the Journal of Laboratory and Clinical Medicine) is accurate, though the creator said 1920, which is slightly off. Glutathione is a tripeptide produced endogenously, and IV glutathione supplementation is used clinically, so that checks out.

BPC-157's reputation for gut and tissue repair comes largely from rodent studies. Seiwerth et al. (2014, Current Pharmaceutical Design) showed GI healing effects in animal models, but human clinical trial data remains sparse. TB-500 (thymosin beta-4) has legitimate tissue repair research behind it, including work by Goldstein and Kleinman (2015, Annals of the New York Academy of Sciences), but again, human evidence is limited. GHK-Cu's skin claims have some support from Pickart et al. (2015, Journal of Aging Research), showing collagen stimulation in vitro and in small trials, but "tightening skin" overstates what the data actually shows.

What did they get wrong (or right)?

The insulin synthesis date is a minor factual error. Banting and Best conducted their experiments in 1921 and published in 1922, not 1920. Small thing, but worth correcting.

More substantively, the creator implies GHK-Cu works for skin when they say "I've given it and taken it" and vaguely affirm it does something. That's anecdote, not evidence. The in-vitro and small-sample data on GHK-Cu is genuinely interesting, but inferring clinical skin-tightening results from personal use is exactly the kind of reasoning that makes peptide discourse messy.

What they got right: the comparison to GLP-1 receptor agonists is sharp. Semaglutide produces visible, rapid weight changes that set an unrealistic expectation for what most peptides can do. The creator is correct that this comparison distorts public perception. They also deserve credit for explicitly stating you do not need peptides and resisting the urge to oversell them, which is rarer than it should be in this content category.

What should you actually know?

Most research-grade peptides like BPC-157 and TB-500 are not FDA-approved for human use. They exist in a regulatory gray zone, often sold as research chemicals. The FDA has also taken action against certain compounded peptides, including placing BPC-157 on a list of withdrawn bulk drug substances in 2023, which limits how compounding pharmacies can use it in the US.

Self-injecting unregulated peptides without labs, clinical oversight, or even knowing the source of what you're using is a genuine safety issue. Contamination, incorrect dosing, and unknown interactions are real risks. The creator flagged this concern, and it deserves to be amplified, not buried. If you are interested in peptide therapy, the evidence-based path involves working with a licensed provider who can order baseline labs, source pharmaceutically verified compounds, and monitor your response over time.